Pharmafile Logo

The Clinical Trial Company

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market.
Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as orphan drug and biologics.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

Mere View Barn, Park Lane, Pickmere, Knutsford, WA16 0LG, UK
+44 1565 733 772

 Latest Content from PMHub 

How can pharma engage with the top performing STPs?

The recent announcement by Health Secretary Jeremy Hunt on which Sustainability and Transformation Partnerships (STPs) would benefit from a share of the £325m capital funding allocated in the Spring Budget,...

Porterhouse Medical announces expansion into the US

  6 November 2017; Reading, UK – UK-based Porterhouse Medical Ltd is delighted to announce the opening of a subsidiary in Philadelphia, PA, USA. The new entity, Porterhouse Medical US, is...

20 questions: Round 7

White Papers and Resources | November 1, 2017 | Inizio

As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What project or event has been most memorable to you at RP?"Watch...

Innovation, sustainability and prosperity: Japan’s healthcare vision for the future

White Papers and Resources | November 1, 2017 | Inizio

The vision for Japan 2035; A healthcare system that delivers unrivalled health outcomes, providing secure and responsive care for all members of society, sustainable, and contributing to prosperity in the...

Tools to action your segmentation

White Papers and Resources | November 1, 2017 | Inizio

Our tools for ensuring a successful segmentation rollout

Research Partnership launches new patient Living with Atopic Dermatitis (US) 2017 report

White Papers and Resources | November 1, 2017 | Inizio

Living with Atopic Dermatitis (AD) is a study conducted amongst 100 adults and 50 caregivers  in the US. The report will consist of 45-minute quantitative and 30-minute qualitative interviews with AD...

The value of design thinking: Incorporating creative and graphic design into pharma market research

White Papers and Resources | November 1, 2017 | Inizio

How do we keep research design fresh and interesting? How do we ensure that we’re inspiring our respondents to give us enlightening new insights, and encourage new ways of thinking?There...

Research Partnership launches new patient Living with Psoriasis 2017 (EU) report

White Papers and Resources | November 1, 2017 | Inizio

Living with Psoriasis is a study conducted amongst 615 patients in Europe. The report will consist of 30-minute online interviews with 600 patients and 15 qualitative interviews. It can be purchased...

Deep Dive – MINT: opportunities in ‘frontier’ markets?

White Papers and Resources | November 1, 2017 | Inizio

According to British economist Jim O’Neill, MINT is the new BRIC. What is MINT? An acronym he coined for the ‘frontier’ markets of Mexico, Indonesia, Nigeria and Turkey. These are...

Webcast: Going for growth – Maximising your return on insights in Emerging Markets

White Papers and Resources | November 1, 2017 | Inizio

Healthcare market research in emerging markets is still evolving, so finding the insights you require and then maximising the return on those insights can be challenging. Healthcare market research in emerging...